ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,857.98
-0.33%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. CorMedix Inc (CRMD)

  7. CorMedix Inc (CRMD) Noticias

CRMD

CorMedix (CRMD)

CorMedix Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CRMD
FechaHoraFuenteTítuloSímboloCompañía
13/05/202415:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
09/05/202416:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CRMDCorMedix Inc
09/05/202407:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRMDCorMedix Inc
09/05/202406:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
19/04/202407:30GlobeNewswire Inc.CorMedix Inc. Announces CMS Grants TDAPA to DefenCathNASDAQ:CRMDCorMedix Inc
15/04/202407:30GlobeNewswire Inc.CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)NASDAQ:CRMDCorMedix Inc
12/03/202406:30GlobeNewswire Inc.CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
18/01/202415:53Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CRMDCorMedix Inc
14/12/202315:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
14/11/202315:05GlobeNewswire Inc.CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
11/10/202307:30GlobeNewswire Inc.CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek ConferenceNASDAQ:CRMDCorMedix Inc
13/09/202316:26Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CRMDCorMedix Inc
13/09/202316:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CRMDCorMedix Inc
13/09/202316:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CRMDCorMedix Inc
08/09/202307:30GlobeNewswire Inc.CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of NephrologyNASDAQ:CRMDCorMedix Inc
30/08/202307:00GlobeNewswire Inc.CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product DefencathNASDAQ:CRMDCorMedix Inc
08/08/202306:30GlobeNewswire Inc.CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
30/06/202315:38Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRMDCorMedix Inc
28/06/202321:57GlobeNewswire Inc.CorMedix Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:CRMDCorMedix Inc
28/06/202316:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CRMDCorMedix Inc
28/06/202315:07GlobeNewswire Inc.CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:CRMDCorMedix Inc
21/06/202307:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRMDCorMedix Inc
21/06/202307:30GlobeNewswire Inc.CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCathNASDAQ:CRMDCorMedix Inc
15/06/202307:30GlobeNewswire Inc.Cormedix Inc. Announces Strategic Initiative With Boston Medical Center to Reduce Health Disparities in Patients at Risk for Bloodstream InfectionsNASDAQ:CRMDCorMedix Inc
19/05/202315:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRMDCorMedix Inc
18/05/202317:26Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CRMDCorMedix Inc
16/05/202306:00GlobeNewswire Inc.CorMedix Inc. Announces Resubmission of New Drug Application for DefenCathNASDAQ:CRMDCorMedix Inc
15/05/202315:05GlobeNewswire Inc.CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
01/05/202307:30GlobeNewswire Inc.CorMedix Inc. Announces Notice of Allowance for U.S. Patent Application Covering Lead Product DefenCathNASDAQ:CRMDCorMedix Inc
26/04/202309:47Dow Jones NewsCorMedix Shares Drop 14% After Type A Meeting With FDA for DefenCathNASDAQ:CRMDCorMedix Inc
 Showing the most relevant articles for your search:NASDAQ:CRMD

Su Consulta Reciente

AMEX
XLV
Health Care Select Sector
FX
EURMXN
Euro vs MXN
USOTC
BASFY
BASF (QX)
NASDAQ
GOOGL
Alphabet
USI
USTECH100
US Tech 100
USOTC
RHHBY
Roche (QX)
NASDAQ
AAPL
Apple
PM
XAUUSD
Gold vs US Dollar
NYSE
KO
Coca Cola
COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
MRK
Merck
NYSE
BAC
Bank of America
AMEX
XLE
Energy Select Sector SPDR
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados